Synergistic Combination of Bioactive Hydroxyapatite Nanoparticles and the Chemotherapeutic Doxorubicin to Overcome Tumor Multidrug Resistance

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy

(2020) Sijin Guo et al.   Nature Communications

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

(2020) Karol Bukowski et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target

(2020) Theo Battista et al.   Cancers

Roles of S100 family members in drug resistance in tumors: Status and prospects

(2020) Xin Hua et al.   BIOMEDICINE & PHARMACOTHERAPY

Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect

(2019) Kun Zhang et al.   Science Advances

Antitumor Effect by Hydroxyapatite Nanospheres: Activation of Mitochondria-Dependent Apoptosis and Negative Regulation of Phosphatidylinositol-3-Kinase/Protein Kinase B Pathway

(2018) Huan Zhao et al.   ACS Nano

Tumor-pH-Responsive Dissociable Albumin-Tamoxifen Nanocomplexes Enabling Efficient Tumor Penetration and Hypoxia Relief for Enhanced Cancer Photodynamic Therapy

(2018) Zhijuan Yang et al.   Small

Mesoporous polydopamine nanoparticles with co-delivery function for overcoming multidrug resistance via synergistic chemo-photothermal therapy

(2017) Yuxin Xing et al.   Nanoscale

Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence

(2017) Jingwei Xue et al.   Nature Nanotechnology

Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment

(2017) Xia Li et al.   Nature Communications

Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer

(2016) Ning Wang et al.   ACS Applied Materials & Interfaces

Mitochondria-Targeted Hydroxyapatite Nanoparticles for Selective Growth Inhibition of Lung Cancer in Vitro and in Vivo

(2016) Yi Sun et al.   ACS Applied Materials & Interfaces

In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles

(2016) Yifan Wang et al.   ACS Nano

Toward a Better Understanding of the Complexity of Cancer Drug Resistance

(2016) Michael M. Gottesman et al.   Annual Review of Pharmacology and Toxicology

Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin

(2016) Hui Xiong et al.   BIOMATERIALS

Correlation of particle properties with cytotoxicity and cellular uptake of hydroxyapatite nanoparticles in human gastric cancer cells

(2016) Xinhui Cui et al.   Materials Science & Engineering C-Materials for Biological Applications

Magnetic Tandem Apoptosis for Overcoming Multidrug-Resistant Cancer

(2016) Mi Hyeon Cho et al.   NANO LETTERS

Doxorubicin-loaded NaYF4:Yb/Tm–TiO2 inorganic photosensitizers for NIR-triggered photodynamic therapy and enhanced chemotherapy in drug-resistant breast cancers

(2015) Leyong Zeng et al.   BIOMATERIALS

Bi 2 S 3 -embedded mesoporous silica nanoparticles for efficient drug delivery and interstitial radiotherapy sensitization

(2015) Ming Ma et al.   BIOMATERIALS

Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance

(2015) Ji Young Yhee et al.   JOURNAL OF CONTROLLED RELEASE

Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor

(2015) Ying Liu et al.   Nature Communications

Porous HA microspheres as drug delivery: Effects of porosity and pore structure on drug loading and in vitro release

(2014) Min Yu et al.   CERAMICS INTERNATIONAL

The potential and advances in RNAi therapy: Chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers

(2014) Min Kyung Joo et al.   JOURNAL OF CONTROLLED RELEASE

Co-Delivery of Doxorubicin and siRNA with Reduction and pH Dually Sensitive Nanocarrier for Synergistic Cancer Therapy

(2014) Weicai Chen et al.   Small

Overcoming Concealment Effects of Targeting Moieties in the PEG Corona: Controlled Permeable Polymersomes Decorated with Folate-Antennae for Selective Targeting of Tumor Cells

(2014) Mohamed A. Yassin et al.   Small

Multidrug resistance: Physiological principles and nanomedical solutions

(2013) Sijumon Kunjachan et al.   ADVANCED DRUG DELIVERY REVIEWS

Differential cytotoxicity and particle action of hydroxyapatite nanoparticles in human cancer cells

(2013) Wei Tang et al.   Nanomedicine

Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle

(2013) R. R. Arvizo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Multifunctional magnetic calcium phosphate nanoparticles for targeted platin delivery

(2012) Smruti R. Rout et al.   DALTON TRANSACTIONS

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

(2012) Yanti Octavia et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Nanoscale hydroxyapatite particles for bone tissue engineering

(2011) Hongjian Zhou et al.   Acta Biomaterialia

The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondria-mediated autophagy

(2011) Ya-Na Wu et al.   BIOMATERIALS

Oxidative stress and apoptosis induced by hydroxyapatite nanoparticles in C6 cells

(2011) Jing Xu et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes

(2010) Kamal K. Upadhyay et al.   BIOMATERIALS

Selective Targeting of Gold Nanorods at the Mitochondria of Cancer Cells: Implications for Cancer Therapy

(2010) Liming Wang et al.   NANO LETTERS

Doxorubicin pathways

(2010) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells

(2009) Yuan Yuan et al.   BIOMATERIALS

Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity

(2009) Masashi Yoshida et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY